Sitemap

๐”๐ง๐ฉ๐š๐œ๐ค๐ข๐ง๐  ๐€๐›๐›๐จ๐ญ๐ญโ€™๐ฌ ๐‘๐ž๐ฏ๐ž๐ง๐ฎ๐ž ๐’๐ญ๐ซ๐ž๐š๐ฆ๐ฌ

2 min readNov 17, 2025

--

Historically, Abbott reported its revenue under two main categories, namely:

1- Diversified Medical Products,
2- Research-based Pharmaceutical Companies.

A significant milestone occurred in 2013, when Abbott split into two independent companies:

  • Abbott (focusing on medical devices, diagnostics, and nutrition),
  • AbbVie (concentrating on pharmaceuticals).

Since the split, Abbott and AbbVie have both thrived in their respective arenas, benefiting from a more focused strategy.

Today, under CEO Robert Fordโ€™s leadership, Abbott generates roughly $42 billion in annual revenue, distributed across its four key segments:

1- Medical Devices (45%),
2- Diagnostics (22%),
3- Nutritional Products (20%),
4- Pharmaceutical Products (12%).

Get Reza Zahiriโ€™s stories inย yourย inbox

Join Medium for free to get updates fromย thisย writer.

Under Lisa Earnhardtโ€™s leadership, Abbottโ€™s Medical Devices, the companyโ€™s largest segment, generates approximately $19 billion in annual revenue, with the following breakdown:

  • Diabetes Care (36%),
  • Vascular (15%),
  • Electrophysiology (13%),
  • Rhythm Management (13%),
  • Structural Heart (12%),
  • Heart Failure (7%),
  • Neuromodulation (5%).

Under Lou Morroneโ€™s leadership, Abbottโ€™s Diagnostics, the companyโ€™s 2nd largest segment, generates $9.3B in annual revenue, with the following breakdown:

  • Core Laboratory (56%),
  • Rapid Diagnostics (32%),
  • Point of Care (6%),
  • Molecular (5%).

Nutritional products under Daniel Salvadoriโ€™s leadership generate $8.4B in annual revenue, with the following breakdown:

  • Adult Nutritionals (52%),
  • Pediatric Nutritionals (48%).

And Pharmaceutical products generate $5.2B in annual revenue, with the following breakdown:

  • Key Emerging Markets (74%),
  • Other (36%).

Today, Abbott stands as the worldโ€™s most valuable medical device company, with a market capitalization exceeding $200 billion and a global workforce of more than 110,000.

Press enter or click to view image in full size

Views are my own. Content is all public data intended for educational purposes, not financial advice. I encourage readers to do their research. Visualization is done with PlotSet.

--

--

Reza Zahiri
Reza Zahiri

Written by Reza Zahiri

Technology executive | Imaging & AI | Author, Decoding MedTech | The strategy and finances of MedTech, pharma and industrial companies, explained in charts